TCL Archive FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005. July 3, 2008
TCL Archive Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says November 8, 2002
TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985